PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2007.39.2.54200739254Autologous Stem Cell Transplantation using a Modified TAM Conditioning Regimen for Clinically Aggressive Non-Hodgkin's LymphomaSook Hee Hong, Young Seon Hong, In Sook Woo, Yoon Ho Koh, Sang Young Rho, Ji Yean Peak, Myung Ah Lee, Byoung Yong Shim, Jae Ho Byun, Ji Chan Park, Jong Wook Lee, Woo Sung Min, Chun Choo Kimhttp://www.e-crt.org/upload/pdf/crt-39-54.pdf, http://www.e-crt.org/upload/pdf/crt-39-54.pdf
10.21203/rs.2.21109/v12020Modified BEAC conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation is safe and effective for invasive B-cell non-Hodgkin’s lymphoma patientsYueyang Li, Yafei Wang, Su Liu, Zehui Chen, Yizhuo Zhang, Yong Yu, Hongliang Yang, Haifeng Zhao, Zhigang Zhao, chen tianhttps://www.researchsquare.com/article/rs-11707/v1, https://www.researchsquare.com/article/rs-11707/v1.html
European Journal of Haematology10.1034/j.1600-0609.2001.00300.x200166143-49Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experienceD. Nachbaur, W. Oberaigner, E. Fritsch, W. Nussbaumer, G. Gasthttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-0609.2001.00300.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-0609.2001.00300.x, http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-0609.2001.00300.x/fullpdf
Bone Marrow Transplantation10.1038/sj.bmt.1703294200229S1S1-S4Autologous stem cell transplantation in follicular non-Hodgkin's lymphomaR Pettengellhttps://www.nature.com/articles/1703294, https://www.nature.com/articles/1703294.pdf, https://www.nature.com/articles/1703294.pdf
Leukemia10.1038/sj.leu.24013281999132282-288The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive casesI Plantier-Colcher, B Dupriez, M Simon, L Detourmignies, JP Jouet, P Fenaux, F Bauters, P Morelhttps://www.nature.com/articles/2401328.pdf, https://www.nature.com/articles/2401328, https://www.nature.com/articles/2401328.pdf
British Journal of Haematology10.1046/j.1365-2141.2003.04446.x20031223457-464Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphomaAvichai Shimoni, Izhar Hardan, Abraham Avigdor, Moshe Yeshurun, Pia Raanani, Isaac Ben-Bassat, Arnon Naglerhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2141.2003.04446.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2141.2003.04446.x, http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04446.x/fullpdf
Biology of Blood and Marrow Transplantation10.1016/j.bbmt.2009.12.1672010162S208-S209Rituximab And Sargramostim Immunotherapy Following Autologous Stem Cell Transplant For Aggressive Non-Hodgkin's LymphomaE. Scigliano, C.L. Grosskreutz, K. Osman, A. Malone, J. Nieto, L.M. Isolahttps://api.elsevier.com/content/article/PII:S1083879109007630?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1083879109007630?httpAccept=text/plain
Hematology and Cell Therapy10.1007/s00282-996-0297-01996384297-304Autologous stem cell transplantation in aggressive non-Hodgkin’s lymphomaC. Gisselbrechthttp://link.springer.com/content/pdf/10.1007/s00282-996-0297-0.pdf, http://link.springer.com/article/10.1007/s00282-996-0297-0/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00282-996-0297-0
Frontiers in Medicine10.3389/fmed.2021.69302320218Case Report: PD-1 Blockade Combined Autologous Hematopoietic Stem Cell Transplantation With Modified BEAM Regimen Containing High-Dose Cytarabine to Treat R/R Hodgkin's LymphomaXiaoqi Wang, Kaniel Cassady, Zhongmin Zou, Xi Zhang, Yimei Fenghttps://www.frontiersin.org/articles/10.3389/fmed.2021.693023/full
Bone Marrow Transplantation10.1038/sj.bmt.17027952001274405-412Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimensA Salar, J Sierra, M Gandarillas, MD Caballero, J Marín, JJ Lahuerta, J García-Conde, R Arranz, A León, J Zuazu, J García-Laraña, A López-Guillermo, MA Sanz, A Grañena, JC García, E Condehttps://www.nature.com/articles/1702795, https://www.nature.com/articles/1702795.pdf, https://www.nature.com/articles/1702795.pdf